Drug Profile
Research programme: androgen receptor antagonists - Karo Pharma
Alternative Names: Androgen receptor antagonists research programme - Karo PharmaLatest Information Update: 21 Dec 2016
Price :
$50
*
At a glance
- Originator Karo Bio
- Class
- Mechanism of Action Androgen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alopecia; Hirsutism; Prostate cancer
Most Recent Events
- 22 Oct 2003 This programme is still in active development
- 25 May 2001 Preclinical development for Alopecia in Sweden (Unknown route)
- 25 May 2001 Preclinical development for Hirsutism in Sweden (Unknown route)